Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells
Document Type: Research Article
Affiliations: 1: Department of Biotherapy, Cancer Research Institute, The First Affiliated Hospital, China Medical University, Shenyang, P.R. China 2: Department of Endocrinology, The Fifth People’s Hospital of Shenyang, Shenyang, P.R. China
Publication date: 24 May 2017
This article was made available online on 27 October 2016 as a Fast Track article with title: "Knockdown of cyclin-dependent kinase inhibitor-3 inhibits proliferation and invasion in human gastric cancer cells".
- Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.